铁亡及其在妊娠糖尿病中的潜在作用:从致病源到治疗的最新证据
Yan Zhao1, Qianqian Gao2, Baoxuan Li1
1Department of Obstetrics and Gynaecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Frontiers in endocrinology
|September 4, 2023
概括
高铁状况与妊娠期糖尿病 (GDM) 有关,这表明铁亡起着作用. 这项研究确定了关键基因,并发现Coptis chinensis是基于铁灭机制的GDM潜在治疗方法.
科学领域:
- 生物医学科学 生物医学科学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 高铁状况与妊娠糖尿病 (GDM) 有关,这表明铁过载和铁死在GDM发展中的作用.
- 铁,一种受调节的细胞死亡形式,与GDM的发病有关.
研究的目的:
- 从传统中医 (TCM) 配方中探索有效的治疗药物,通过研究铁死来治疗GDM.
- 为了确定关键的基因和分子标与GDM中的ferroptosis相关.
主要方法:
- 在使用临床和实验数据 (电子显微镜,西部涂抹) 的GDM胎盘中验证了铁.
- 分析了转录组测序数据与差异基因表达 (DEGs) 和权重基因共同表达网络分析 (WGCNA).
- 构建了蛋白质-蛋白质相互作用 (PPI) 网络,确定了关键基因 (SF3B14,BABAM1),并与TCM化合物进行了分子对接和动态模拟.
主要成果:
- 在GDM胎盘组织中增加了费里丁水平,并确认了胎盘亡.
- 确定了99个关键的与铁灭相关的基因,其中DEGs主要参与氧化酸化.
- 科普蒂斯chinensis被确定为一个有前途的草药候选人GDM治疗在分子水平.
结论:
- 铁化存在于GDM患者中,与铁化相关的基因可能调节GDM病变发生.
- 这项研究为GDM分子机制提供了新的见解,并为优化GDM管理的TCM公式提供了基础.
更多相关视频
相关概念视频
Pathophysiology of Diabetes
986
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
986
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes: Management and Pharmacotherapy
310
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
310


